Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myeloma

Multiple Myeloma (MM) is a haematological neoplasm characterised by the clonal proliferation of malignant plasma cells in the bone marrow. The success of proteasome inhibitors in the treatment of MM has highlighted the importance of the ubiquitin proteasome system (UPS) in the pathogenesis of this d...

Descripción completa

Detalles Bibliográficos
Autores principales: Crawford, Lisa J., Anderson, Gordon, Johnston, Cliona K., Irvine, Alexandra E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342567/
https://www.ncbi.nlm.nih.gov/pubmed/27655696
http://dx.doi.org/10.18632/oncotarget.12026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342567/
https://www.ncbi.nlm.nih.gov/pubmed/27655696
http://dx.doi.org/10.18632/oncotarget.12026

Ejemplares similares